Moreover, US3 can also act as an inhibitor of NF-κB signaling by reducing the polyubiquitination of TRAF6 through its kinase activity and inhibiting Toll-like receptor 2 (TLR2) signaling at the early stage of viral infection (14). Here, NFKB1 is linked to viral infectious disease.